|
Volumn 132, Issue 1, 2014, Pages 111-114
|
Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
CARBOPLATIN;
CORTICOSTEROID;
ERLOTINIB;
IRINOTECAN;
RAPAMYCIN;
TEMOZOLOMIDE;
VINBLASTINE;
VINCRISTINE;
ADOLESCENT;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CASE REPORT;
CHILD;
CORTICOSTEROID THERAPY;
DISEASE COURSE;
FEMALE;
HEMIANOPIA;
HUMAN;
MONOTHERAPY;
NEUROFIBROMATOSIS;
OPTIC NERVE GLIOMA;
PERIMETRY;
PRIORITY JOURNAL;
PROTON THERAPY;
SCHOOL CHILD;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TUMOR VOLUME;
VISUAL ACUITY;
VISUAL FIELD DEFECT;
VISUAL IMPAIRMENT;
ADOLESCENT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHILD;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENOUS;
MAGNETIC RESONANCE IMAGING;
OPTIC CHIASM;
OPTIC NERVE GLIOMA;
OPTIC NERVE NEOPLASMS;
RECOVERY OF FUNCTION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISION, OCULAR;
VISUAL ACUITY;
VISUAL FIELD TESTS;
VISUAL FIELDS;
|
EID: 84892733049
PISSN: 21686165
EISSN: None
Source Type: Journal
DOI: 10.1001/jamaophthalmol.2013.5819 Document Type: Article |
Times cited : (98)
|
References (5)
|